The efpeglenatide shot costs about 129,800 won for the first four weeks, and Korean phase 3 data showed 9.75% average weight loss over 40 weeks.
Recap by typeshit. Full story at 헤럴드경제.
The 52-year-old actor points to his early 4am workouts and discipline instead of weight loss shots. A celebrity opinion, not new data.
Metz says the drug improved her mobility enough to handle eight Broadway shows a week in "& Juliet". Her account, not a clinical claim.
A general piece on how GLP-1 drugs like Ozempic and Wegovy reshaped weight management in the US. Light on new details.
The broker says Laurus beat 2QFY27 estimates on EBITDA and profit, with its CDMO pipeline and peptide work driving the higher forecasts.
Famtimes says habits like diet and exercise matter for keeping weight off once GLP-1 treatment ends.
The once-daily tablet also trimmed weight about 4% over 13 weeks, with no dropouts from stomach side effects, the company reports. Obesity phase III data are due in 2028.
Loading…